Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3M Sell
520,958
-17,887
-3% -$398K 0.05% 325
2026
Q1
$12.7M Buy
538,845
+144,176
+37% +$3.12M 0.06% 274
2025
Q4
$13.5M Buy
+394,669
New +$11.7M 0.06% 264
2025
Q1
$11.7M Buy
325,064
+158,411
+95% +$6.37M 0.06% 323
2024
Q4
$6.98M Buy
+166,653
New +$6.05M 0.04% 385
2024
Q2
Sell
-4,782
Closed -$212K 1361
2024
Q1
$212K Buy
+4,782
New +$258K ﹤0.01% 1170

Other funds holding BRZE

Glenmede Trust's BRZE Position: Q2 2026 in Review

Glenmede Trust reduced its Braze (BRZE) stake by 3.3% in Q2 2026, selling an estimated $398K and leaving 520,958 shares worth $11.3M. The position accounts for 0.05% of the portfolio, ranked #325.

Glenmede Trust first reported a position in BRZE in Q1 2024 and has held it in 6 quarters since. The position peaked at $13.5M in Q4 2025. 245 funds tracked by Wall St. Rank hold BRZE as of Q2 2026.

  • Glenmede Trust held 520,958 shares of Braze worth $11.3M as of Q2 2026.
  • Glenmede Trust sold 17,887 Braze shares in Q2 2026, an estimated $398K.
  • Braze made up 0.05% of Glenmede Trust's portfolio in Q2 2026, its #325 holding.
  • Glenmede Trust first reported a position in Braze in Q1 2024 and has held it in 6 quarters since.
  • Glenmede Trust's Braze position peaked at $13.5M in Q4 2025.
  • 245 funds tracked by Wall St. Rank held Braze as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.